Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.3 SEK | -2.75% |
|
-5.36% | +1.92% |
15/05 | Brilliant Future AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
24/04 | Perpetua Medical Names New CFO | MT |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | 99.78 | 48.78 | 71.72 |
Enterprise Value (EV) 1 | 82.46 | 46.81 | 49.36 |
P/E ratio | -3.85 x | -1.52 x | -5.91 x |
Yield | - | - | - |
Capitalization / Revenue | 1.01 x | 0.53 x | 0.72 x |
EV / Revenue | 1.01 x | 0.53 x | 0.72 x |
EV / EBITDA | -5.06 x | -1.93 x | -17.9 x |
EV / FCF | -32,55,155 x | -37,27,303 x | -88,12,308 x |
FCF Yield | -0% | -0% | -0% |
Price to Book | 2.47 x | 3.3 x | 1.81 x |
Nbr of stocks (in thousands) | 7,391 | 7,391 | 13,793 |
Reference price 2 | 13.50 | 6.600 | 5.200 |
Announcement Date | 03/05/22 | 14/04/23 | 23/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 100 | 96.16 | 99.91 | 99.06 | 92.41 | 100 |
EBITDA 1 | 14.08 | 0.156 | -1.275 | -19.72 | -25.3 | -4.01 |
EBIT 1 | 13.9 | 0.032 | -3.798 | -26.17 | -32.11 | -11.59 |
Operating Margin | 13.9% | 0.03% | -3.8% | -26.41% | -34.75% | -11.59% |
Earnings before Tax (EBT) 1 | 0.162 | 0.068 | -3.924 | -26.18 | -32.52 | -11.18 |
Net income 1 | 0.053 | 0.008 | -4.266 | -25.92 | -32.52 | -11.18 |
Net margin | 0.05% | 0.01% | -4.27% | -26.17% | -35.19% | -11.18% |
EPS | - | - | -0.5800 | -3.510 | -4.340 | -0.8800 |
Free Cash Flow | - | 0.00225 | 17.53 | -30.65 | -13.09 | -8.139 |
FCF margin | - | 0% | 17.55% | -30.94% | -14.16% | -8.14% |
FCF Conversion (EBITDA) | - | 1.44% | - | - | - | - |
FCF Conversion (Net income) | - | 28.12% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 29/04/20 | 29/04/20 | 03/05/22 | 03/05/22 | 14/04/23 | 23/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | - | 19.2 | 17.3 | 1.97 | 22.4 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | 0 | 17.5 | -30.7 | -13.1 | -8.14 |
ROE (net income / shareholders' equity) | - | 0.03% | -15.4% | -77.5% | -112% | -39% |
ROA (Net income/ Total Assets) | - | 0.03% | -3.6% | -21.3% | -24.4% | -8.13% |
Assets 1 | - | 24.62 | 118.6 | 121.7 | 133.1 | 137.5 |
Book Value Per Share | - | - | 3.570 | 5.480 | 2.000 | 2.870 |
Cash Flow per Share | - | - | 2.600 | 2.340 | 2.480 | 1.620 |
Capex 1 | 0.33 | - | - | 1.48 | 0.3 | 0.05 |
Capex / Sales | 0.33% | - | - | 1.5% | 0.32% | 0.05% |
Announcement Date | 29/04/20 | 29/04/20 | 03/05/22 | 03/05/22 | 14/04/23 | 23/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+1.92% | 6.98M | |
-10.59% | 234B | |
+2.99% | 59.86B | |
-20.64% | 56.93B | |
-3.14% | 38.83B | |
+1.64% | 36.63B | |
-10.34% | 28.43B | |
+97.19% | 25.39B | |
+1.29% | 21.08B | |
+5.04% | 13.91B |
- Stock Market
- Equities
- BRILL Stock
- Financials Brilliant Future AB